Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for upper limb motor recovery after stroke
ACTRN12619000573156Phase 2Withdrawn
- Sponsor
- The University of Auckland
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in stroke comparing Fluoxetine with Placebo (2 arms). Primary endpoint: Change in upper extremity Fugl-Meyer score. Planned start Jun 2019; status: withdrawn.
02
Drugs
fluoxetine
03
Conditions
stroke
Beyond the preview
Go deeper on ACTRN12619000573156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000573156.